HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emma S Jones Selected Research

CGP 42112A

2/2020Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil.
11/2013Direct ATâ‚‚ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient mice.
8/2012Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emma S Jones Research Topics

Disease

4Fibrosis (Cirrhosis)
02/2020 - 11/2004
4Hypertension (High Blood Pressure)
11/2012 - 04/2008
3Cardiovascular Diseases (Cardiovascular Disease)
02/2013 - 12/2008
2Hypertrophy
01/2012 - 11/2004
1COVID-19
01/2022
1Zoonoses
01/2022
1Neoplasms (Cancer)
07/2014
1Atherosclerosis
11/2013
1Rupture
11/2013
1Inflammation (Inflammations)
11/2012
1Ischemia
08/2012
1Infarction (Infarctions)
08/2012
1Brain Ischemia (Cerebral Ischemia)
08/2012
1Ischemic Stroke
08/2012
1Vascular Remodeling
07/2012
1Myocardial Infarction
04/2011
1Cardiomegaly (Heart Hypertrophy)
11/2004

Drug/Important Bio-Agent (IBA)

4Type 2 Angiotensin ReceptorIBA
07/2014 - 02/2012
3candesartan cilexetil (Amias)FDA Link
02/2020 - 11/2004
3CGP 42112AIBA
02/2020 - 08/2012
2SaltsIBA
02/2020 - 11/2012
2Pharmaceutical PreparationsIBA
07/2014 - 04/2011
2Angiotensin Receptors (Angiotensin II Receptor)IBA
07/2014 - 08/2012
2compound 21IBA
02/2013 - 04/2011
2PD 123319IBA
01/2012 - 11/2004
2AngiotensinsIBA
12/2008 - 04/2008
1VaccinesIBA
01/2022
1human serelaxin proteinIBA
02/2020
1RelaxinIBA
07/2014
1LipidsIBA
11/2013
1Phenobarbital (Luminal)FDA Link
11/2013
1LigandsIBA
02/2013
1ChemokinesIBA
11/2012
1INCB3344IBA
11/2012
1Acetates (Acetic Acid Esters)FDA Link
11/2012
1Desoxycorticosterone (Deoxycorticosterone)IBA
11/2012
1Messenger RNA (mRNA)IBA
11/2012
1Cytokine Receptors (Cytokine Receptor)IBA
11/2012
1Chemokine ReceptorsIBA
11/2012
1Desoxycorticosterone Acetate (DOCA)FDA Link
11/2012
1Neuroprotective AgentsIBA
08/2012
1Angiotensin IIIBA
07/2012
1Peptide FragmentsIBA
12/2008
1Peptides (Polypeptides)IBA
12/2008
1Vasodilator Agents (Vasodilators)IBA
04/2008
1Antihypertensive Agents (Antihypertensives)IBA
04/2008

Therapy/Procedure

1Personal Protective Equipment
01/2022